Immunai

AI-powered platform decoding the human immune system for therapeutics.

BiotechnologyArtificial Intelligence immunai.com ↗

Company facts

Founded
2018
Employees
180
Headquarters
United States
Type
Private
Funding
Series C · $219M · 2021
Subsidiaries
Nebion, Dropprint Genomics